The Intrinsic Cardiac Nervous System: From Pathophysiology to Therapeutic Implications
Authors:
- Giuseppe GianninoGGGiuseppe Giannino
- Valentina BraiaVBValentina Braia
- Carola Griffith BrooklesCBCarola Griffith Brookles
- Federico GiacobbeFGFederico Giacobbe
- Fabrizio D’ascenzoFDFabrizio D’ascenzo
- Filippo AngeliniFAFilippo Angelini
- Andrea SagliettoASAndrea Saglietto
- Gaetano Maria De FerrariGFGaetano Maria De Ferrari
- Veronica DusiVDVeronica Dusi
Top Cited Papers
Open Access
Abstract
The cardiac autonomic nervous system (CANS) plays a pivotal role in cardiac homeostasis as well as in cardiac pathology. The first level of cardiac autonomic control, the intrinsic cardiac nervous system (ICNS), is located within the epicardial fat pads and is physically organized in ganglionated plexi (GPs). The ICNS system does not only contain parasympathetic cardiac efferent neurons, as long believed, but also afferent neurons and local circuit neurons. Thanks to its high degree of connectivity, combined with neuronal plasticity and memory capacity, the ICNS allows for a beat-to-beat control of all cardiac functions and responses as well as integration with extracardiac and higher centers for longer-term cardiovascular reflexes. The present review provides a detailed overview of the current knowledge of the bidirectional connection between the ICNS and the most studied cardiac pathologies/conditions (myocardial infarction, heart failure, arrhythmias and heart transplant) and the potential therapeutic implications. Indeed, GP modulation with efferent activity inhibition, differently achieved, has been studied for atrial fibrillation and functional bradyarrhythmias, while GP modulation with efferent activity stimulation has been evaluated for myocardial infarction, heart failure and ventricular arrhythmias. Electrical therapy has the unique potential to allow for both kinds of ICNS modulation while preserving the anatomical integrity of the system.Keywords
This publication has 194 references indexed in Scilit:
- An Inotropic Action Caused by Muscarinic Receptor Subtype 3 in Canine Cardiac Purkinje FibersISRN Pharmacology, 2013
- The cardiac sympathetic co-transmitter galanin reduces acetylcholine release and vagal bradycardia: Implications for neural control of cardiac excitabilityJournal of Molecular and Cellular Cardiology, 2012
- Processing of central and reflex vagal drives by rat cardiac ganglion neurones: an intracellular analysisThe Journal of Physiology, 2011
- Guide to Receptors and Channels (GRAC), 5th editionBritish Journal of Pharmacology, 2011
- Heart failure causes cholinergic transdifferentiation of cardiac sympathetic nerves via gp130-signaling cytokines in rodentsJournal of Clinical Investigation, 2010
- BMP signaling regulates sympathetic nervous system development through Smad4-dependent and -independent pathwaysDevelopment, 2009
- Chronic myocardial infarction induces phenotypic and functional remodeling in the guinea pig cardiac plexusAmerican Journal of Physiology-Regulatory, Integrative and Comparative Physiology, 2008
- Atrial Fibrillation Begets Atrial FibrillationCirculation: Arrhythmia and Electrophysiology, 2008
- Potential clinical relevance of the ‘little brain’ on the mammalian heartExperimental Physiology, 2008
- Cells migrating from the neural crest contribute to the innervation of the venous pole of the heartJournal of Anatomy, 2007